Anti-HIV drug, tenofovir, can be used during pregnancy
Rachel Ogbu
WVoN co-editor
New research suggests that the use of the anti-HIV drug, tenofovir, during pregnancy is safe for infants.
According to HealthDay, the new findings from the National Institutes of Health network, should reassure pregnant women with HIV who are taking tenofovir.
Science Codex reports that babies born to women who took it as part of an anti-HIV drug regimen during pregnancy, did not weigh less at birth and were not shorter than babies born to women whose drug regimen did not include tenofovir.
Previous studies had shown that laboratory animals exposed to the drug in the womb were smaller at birth than those who were not exposed to it.
The new study included 2,000 infants born to HIV-positive mothers between 2003 and 2010 in the United States. The researchers said, however, that further studies should be conducted to identify any potential long-term effects of taking tenofovir during pregnancy.
Dr. George Siberry, of the Pediatric, Adolescent and Maternal AIDS Branch of the US National Institute of Child Health and Human Development, and the first author of the study said that, overall, it provided reassuring information regarding the use of the drug during pregnancy.












